IP Library › Granted Patent US 12,544,331
Granted Patent B2
US 12,544,331 · App. 18/522,676 · Granted Feb 10, 2026

Lubricant formulations

Inventors: Kurt Richards (Herriman, UT); Andrew Hoover (Pleasant Grove, UT)
Assignee: Reoxcyn, LLC
A61K9/0034A61K8/0216A61K8/20A61K8/24A61K8/25A61K8/891A61K33/20A61K47/02A61K47/34A61L31/14A61L31/16A61Q17/005A61Q19/00A61L2300/404A61L2400/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,544,331
App. No.
18/522,676
Granted
Feb 10, 2026
Kind
B2
Abstract

A composition for lubricant formulations is disclosed. The composition may include hypochlorite, dimethicone, and an emulsifier for improvement of lubricity. Methods of making and using the lubricant formulations are also disclosed.

Claims (17)

1 . A method of inhibiting a microbial infection, the method comprising:

providing a lubricant comprising:

an electrolyzed saline solution;

a rheology modifier; and

a polymeric organosilicon compound; and

applying the lubricant to a microbial infection; and wherein the rheology modifier comprises sodium magnesium silicate.

2 . The method of claim 1 , wherein the infection is a viral infection.

3 . The method of claim 2 , wherein the viral infection comprises an HIV, HSV, or HBV infection.

4 . The method of claim 1 , wherein the infection is a bacterial infection.

5 . The method of claim 4 , wherein the bacterial infection comprises a chlamydia, gonorrhoeae, Gardnerella, Mycoplasma , or Campylobacter infection.

6 . The method of claim 1 , wherein the infection is a fungal infection.

7 . The method of claim 6 , wherein the fungal infection is caused by one or more species of yeast of the Candida genus.

8 . The method of claim 7 , wherein the species of yeast of the Candida genus is selected from the group consisting of Candida albicans, Candida dubliniensis, Candida parapsilosis, Candida tropicalis, Candida kerfyr, Candida guilliermondii, Candida inconspicua, Candida famata, Candida glabrata, Candida krusei, Candida lusitaniae , and combinations thereof.

9 . The method of claim 1 , wherein the electrolyzed saline solution comprises hypochlorite present in an amount of about 10 to about 300 ppm.

10 . The method of claim 1 , wherein the polymeric organosilicon compound is dimethicone.

11 . The method of claim 1 , wherein the polymeric organosilicon compound is present in an amount of about 0.5% to about 50% w/v.

12 . The method of claim 1 , wherein the rheology modifier comprises sodium magnesium silicate present in an amount of about 0.1% to about 15% w/v.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 5, 2023
From: RICHARDS, KURT; HOOVER, ANDREW
To: REOXCYN DISCOVERIES GROUP, INC.
Reel/Frame 065766/0137 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 5, 2023
From: REOXCYN DISCOVERIES GROUP, INC.
To: REOXCYN INNOVATION GROUP, LLC
Reel/Frame 065770/0020 →
CHANGE OF NAME Recorded Dec 5, 2023
From: REOXCYN INNOVATION GROUP, LLC
To: REOXCYN, LLC
Reel/Frame 065788/0327 →
Continuity (6)
Continuation 17444648 · Aug 6, 2021
Continuation 16671707 · Nov 1, 2019
Continuation 15818531 · Nov 20, 2017
Division 15266147 · Sep 15, 2016
Continuation 15158442 · May 18, 2016
Related Publication 20240342078A1 · Oct 17, 2024
References Cited (104)
US 1200165A · Burgess · 1916 [cited by applicant]
US 4236992A · Themy · 1980 [cited by applicant]
US 4316787A · Themy · 1982 [cited by applicant]
US 4671955A · Palinczar · 1987 [cited by examiner]
US 4810344A · Okazaki · 1989 [cited by applicant]
US 4956184A · Kross · 1990 [cited by applicant]
US 5334383A · Morrow · 1994 [cited by applicant]
US 5507932A · Robinson · 1996 [cited by applicant]
US 5674537A · Morrow · 1997 [cited by applicant]
US 6007686A · Welch · 1999 [cited by applicant]
US 6114398A · Ratcliff · 2000 [cited by applicant]
US 6117285A · Welch · 2000 [cited by applicant]
US 6333054B1 · Rogozinski · 2001 [cited by applicant]
US 7108997B2 · Kettle · 2006 [cited by applicant]
US 7622434B2 · Rogozinski · 2009 [cited by applicant]
US 7691249B2 · Daly · 2010 [cited by applicant]
US 8062501B2 · Omasa · 2011 [cited by applicant]
US 8323252B2 · Alimi · 2012 [cited by applicant]
US 8518382B2 · Speronello et al. · 2013 [cited by applicant]
US 8673297B2 · Speronello et al. · 2014 [cited by applicant]
US 8784900B2 · Northey · 2014 [cited by applicant]
US 9072793B2 · Eckert et al. · 2015 [cited by applicant]
US 9175141B2 · Wray et al. · 2015 [cited by applicant]
US 9474768B1 · Richards et al. · 2016 [cited by applicant]
US 9833406B1 · Richards · 2017 [cited by applicant]
US 10471003B2 · Richards et al. · 2019 [cited by applicant]
US 20020114849A1 · Camper et al. · 2002 [cited by applicant]
US 20050089537A1 · Birnholz · 2005 [cited by applicant]
US 20050196462A1 · Alimi · 2005 [cited by applicant]
US 20060241546A1 · Alimi · 2006 [cited by applicant]
US 20070020213A1 · Tamarkin · 2007 [cited by examiner]
US 20070021213A1 · Foe · 2007 [cited by applicant]
US 20070172412A1 · Hratko et al. · 2007 [cited by applicant]
US 20070281008A1 · Lin et al. · 2007 [cited by applicant]
US 20080003171A1 · Smith et al. · 2008 [cited by applicant]
US 20080008621A1 · Masahiro et al. · 2008 [cited by applicant]
US 20080160612A1 · Selkon · 2008 [cited by applicant]
US 20090028811A1 · Potter · 2009 [cited by applicant]
US 20090068122A1 · Shira et al. · 2009 [cited by applicant]
US 20090107513A1 · Zedalis · 2009 [cited by applicant]
US 20090148342A1 · Bromberg et al. · 2009 [cited by applicant]
US 20090169646A1 · Bosch et al. · 2009 [cited by applicant]
US 20090258083A1 · Calderon · 2009 [cited by applicant]
US 20100012132A1 · Harrison et al. · 2010 [cited by applicant]
US 20100078331A1 · Scherson · 2010 [cited by applicant]
US 20100197748A1 · Schwarz et al. · 2010 [cited by applicant]
US 20100285151A1 · Goldan · 2010 [cited by applicant]
US 20100330203A1 · Kross · 2010 [cited by applicant]
US 20110052506A1 · Abel · 2011 [cited by applicant]
US 20110121110A1 · Field · 2011 [cited by applicant]
US 20120046556A1 · Block · 2012 [cited by applicant]
US 20120148516A1 · Abel · 2012 [cited by applicant]
US 20120164235A1 · Northey · 2012 [cited by applicant]
US 20120237616A1 · Panicheva · 2012 [cited by applicant]
US 20130164228A1 · Stanislav et al. · 2013 [cited by applicant]
US 20130168260A1 · Scherson et al. · 2013 [cited by applicant]
US 20130236563A1 · Samuelson · 2013 [cited by applicant]
US 20140044800A1 · Robinson · 2014 [cited by applicant]
US 20140328946A1 · Northey · 2014 [cited by applicant]
US 20140369953A1 · Purschwitz · 2014 [cited by applicant]
US 20150017257A1 · Megumi et al. · 2015 [cited by applicant]
US 20150093451A1 · Neiman · 2015 [cited by applicant]
US 20150099010A1 · Hoover · 2015 [cited by applicant]
US 20150118180A1 · Hoover · 2015 [cited by applicant]
US 20150125543A1 · Croke et al. · 2015 [cited by applicant]
US 20150246131A1 · Romanoschi et al. · 2015 [cited by applicant]
US 20150250704A1 · Romanoschi et al. · 2015 [cited by applicant]
CN 102167997 · 2013 [cited by applicant]
CN 104476966 · 2015 [cited by applicant]
CN 104922055 · 2015 [cited by applicant]
EP 0335584 · 1989 [cited by applicant]
EP 1886664 · 2008 [cited by applicant]
JP 50103897 · 1975 [cited by applicant]
JP S50103897 · 1975 [cited by applicant]
JP 9208715 · 1997 [cited by applicant]
JP H10179721 · 1998 [cited by applicant]
JP 3504815 · 2004 [cited by applicant]
JP 2006312046 · 2006 [cited by applicant]
JP 10179721 · 2010 [cited by applicant]
JP 2013505062 · 2013 [cited by applicant]
WO WO9934773 · 1999 [cited by applicant]
WO WO2010004699 · 2010 [cited by applicant]
WO WO2015002932 · 2015 [cited by applicant]
WO WO2016100543 · 2016 [cited by applicant]
WO WO2017127452 · 2017 [cited by applicant]
“High purity, activated HCIO Perfect Perio”, http://amanodental.com/english/PerfectPerio-how-to-use.pdf, Nov. 2010. [cited by applicant]
Ahmed et al.; “Effectiveness of 0.025% Dakin's Solution Versus 1 % Silver Sulphadiazine for Treatment of Partial Thickness Burns,” Ann. Pak. Inst. Med. Sci. 2011; 7(3): 127-132. [cited by applicant]
Alnashef et al. Electrochemical Generation of Superoxide In Room-Termperature lonic Liquids. Electrochemical and Solid State Letters, 4 (11) D16-D18 (2001). [cited by applicant]
AlNashef et al. Superoxide Electrochemistry in an Ionic Liquid. Ind. Eng. Chem. Res. 2002, 41, 4475-4478. [cited by applicant]
Bielski et al. Reactivity of H02/02- Radicals in Aqueous Solution. J. Phys. Chem. Ref. Data, vol. 14, No. 4 1985. [cited by applicant]
Chen, “Novel technologies for the prevention and treatment of dental caries: a patent survey”, Expert Opin Ther Pat. May 2010; 20(5): 681-694. [cited by applicant]
Hayann et al. Generation and stability of superoxide ion in tris(pentafluoroethyl) trifluorophosphate anion-based ionic liquids. J Fluorine Chem. vol. 142, 2012, 83-89. [cited by applicant]
Hayyan et al. Long term stability of superoxide ion in piperidinium, pyrrolidinium and phosphonium cations-based ionic liquids and its utilization in the destruction of chlorobenzenes. Journal of Electroanalytical Chemi… [cited by applicant]
International Search Report and Written Opinion for PCT/US2017/013979, mailed May 2, 2017. [cited by applicant]
Kahn et al. Spin Traps: In Vitro Toxicity and Stability of Radical Adducts. Free Radical Biology & Medicine, vol. 34, No. 11, pp. 1473-1481, 2003. [cited by applicant]
Kariduraganavar et al. Ion-exchange membranes: preparative methods for electrodialysis and fuel cell applications. Desalination 197 (2006) 225-246. [cited by applicant]
Konaka et al. Irradiation of Titanium Dioxide Generates Both Singlet Oxygen and Superoxide Anion. Free Radical Biology & Medicine, vol. 27, Nos. 3/4, pp. 294-300, 1999. [cited by applicant]
Notice of Allowance issued in application No. JP 2018-232443, date Dec. 7, 2020. [cited by applicant]
Notice of Reasons for Rejection issued in Japanese application No. 2016-212701, mailed Sep. 3, 2018. [cited by applicant]
Office Action issued in CN application No. 201710127546.7 dated Nov. 4, 2020. [cited by applicant]
PCT International Search Report in PCT/US2017/051283, mailed Nov. 29, 2017. [cited by applicant]
PCT Search Report and Written Opinion for PCT Application No. PCT/US2016/056760, filed Oct. 13, 2016, dated Jan. 16, 2017. [cited by applicant]
Prasanth, “Antimicrobial Efficacy of Different Toothpastes and Mouthrinses: an In Vitro Study”, Dent Res J (Isfahan), 2011 Spring, 8(2); 85-94. [cited by applicant]
Zoulias et al. A Review on Water Electrolysis last modified Jan. 20, 2006 15:24. [cited by applicant]